Hendrika M. Hazendonk
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial): an open-label, multicentre, randomised, controlled trial.
Journal: The Lancet. Haematology
Published: February 22, 2021
Validation of a perioperative population factor VIII pharmacokinetic model with a large cohort of pediatric hemophilia a patients.
Journal: British journal of clinical pharmacology
Published: December 20, 2020
Dosing of factor VIII concentrate by ideal body weight is more accurate in overweight and obese haemophilia A patients.
Journal: British journal of clinical pharmacology
Published: December 18, 2019
Current dosing practices for perioperative factor VIII concentrate treatment in mild haemophilia A patients result in FVIII levels above target.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: November 26, 2018
Predictors of oral cavity bleeding and clinical outcome after dental procedures in patients on vitamin K antagonists. A cohort study.
Journal: Thrombosis and haemostasis
Published: January 19, 2017
A population pharmacokinetic model for perioperative dosing of factor VIII in hemophilia A patients.
A population pharmacokinetic model for perioperative dosing of factor VIII in hemophilia A patients.
Journal: Haematologica
Published: September 06, 2015
The "OPTI-CLOT" trial. A randomised controlled trial on periOperative PharmacokineTIc-guided dosing of CLOTting factor concentrate in haemophilia A.
Journal: Thrombosis and haemostasis
Published: November 10, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026